Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
Clinical trial NCT07371338 · RECRUITING
Trial details
- NCT number
- NCT07371338
- Sponsor
- Innopeutics Corporation
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2027-10-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.